We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies

16 hedge funds and large institutions have $3.33M invested in CollPlant Biotechnologies in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

14% more funds holding

Funds holding: 1416 (+2)

0.16% more ownership

Funds ownership: 11.12%11.28% (+0.16%)

27% less capital invested

Capital invested by funds: $4.59M → $3.33M (-$1.25M)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

CLGN Hedge Fund Activity: Q1 2025 in Review

16 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q1 2025, worth a combined $3.33M — down 27% from $4.59M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CLGN positions and 0 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Waters Parkerson & Co, opening a new position worth an estimated $46.7K. The largest seller was Brown Advisory, cutting an estimated $29.1K.

  • 16 institutional investors held CollPlant Biotechnologies (CLGN) as of Q1 2025, up from 14 in Q4 2024.
  • Funds reported $3.33M of CollPlant Biotechnologies stock for Q1 2025, down 27% quarter-over-quarter.
  • 2 funds opened new CollPlant Biotechnologies positions in Q1 2025 and 0 closed out, a net change of +2 holders.
  • The largest CollPlant Biotechnologies buyer in Q1 2025 was Waters Parkerson & Co, an estimated $46.7K added.
  • The largest CollPlant Biotechnologies seller in Q1 2025 was Brown Advisory, an estimated $29.1K sold.

Based on aggregated 13F filings for Q1 2025.